Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones

Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the issuance of a new patent for the company’s...

Related Keywords

San Diego ,California ,United States ,American ,Antoniof Santidrian ,Allan Camaisa ,Calidi Biotherapeutics ,Trademark Office ,Northwestern University ,Company Registration ,Calidi Biotherapeutics Inc ,United States Patent ,Chief Scientific Officer ,Clinical Milestones ,Note Regarding Forward Looking ,Registration Statements ,Markets ,